Our Approach
A Phased Commercial Staircase
One neutron platform, progressively upgraded — generating value at every stage while advancing toward clean fusion energy.
Phase 1
2026–2029Cancer Therapy & Industrial Inspection
An accelerator produces epithermal neutrons for Boron Neutron Capture Therapy — India's first BNCT facility, targeting head & neck cancers with minimal healthy-tissue damage. The same device simultaneously provides precision neutron non-destructive evaluation (NDE) for aerospace and defence.
Phase 2
2026–2030 Concurrent with Phase 1Medical Isotope Production
A magnetic mirror fusion device becomes India's first domestic fast-neutron isotope source, producing a portfolio of medical isotopes for oncology and nuclear medicine — including Tc-99m, Lu-177, Cu-64, Sc-47, and others currently 100% imported.
Phase 3
2031–2036Hybrid Energy Systems
The device is upgraded and coupled with a sub-critical blanket to address nuclear waste management, advanced fuel breeding, and grid-scale electricity generation — three national priorities from a single machine.
Phase 4
2036 onwardsClean Fusion Power
The upgraded mirror device achieves near-aneutronic fusion, producing grid-scale clean electricity with minimal radioactive waste — the long-term vision for baseload energy independence.
What We Do
Our Applications
A single neutron platform serves medicine, industry, energy, and research — each application reinforcing the others.
Medicine & Healthcare
BNCT Cancer Therapy
Precision cellular-level radiation treatment for head & neck cancers, sparing healthy tissue entirely.
Medical Isotope Production
Domestic production of Tc-99m, Lu-177, Cu-64, Sc-47, Y-90 and other isotopes for cancer diagnostics and therapy.
Sealed Source Production
Calibration and reference sources for medical instruments, radiation monitoring, and nuclear metrology.
Industry
Neutron NDE & Radiography
Non-destructive evaluation of aerospace composites, EV batteries, and additive-manufactured components — seeing what X-rays cannot.
PGNAA Process Control
Real-time elemental analysis for on-line quality control in cement, coal, and mineral processing plants.
Materials Irradiation Testing
Radiation hardness qualification for satellites, semiconductors, and space-grade components.
Security & Cargo Inspection
Active neutron interrogation for explosive and fissile material detection at ports and borders.
Energy
Research & Knowledge
Neutron Activation Analysis
Multi-element compositional analysis for archaeology, art authentication, and environmental tracing.
Research Isotopes & Tracers
Custom isotope production for nuclear physics, chemistry research, and diagnostic tracer development.
NuKG Knowledge Platform
A nuclear knowledge graph platform accelerating R&D across the nuclear science community.
Our Technology
Built on Proven Physics
Our technology platform draws on decades of plasma physics research, adapted for near-term commercial applications.
Neutron Source Design
Advanced moderator and reflector assemblies optimised through Monte Carlo simulation for epithermal beams serving both BNCT therapy and industrial NDE.
Progressive Platform
A single linear device progressively upgraded — from accelerator to magnetic mirror to advanced operations — each stage funding the next.
Computational Tools
Proprietary simulation and nuclear knowledge graph platforms that accelerate R&D and serve the broader nuclear science community.
Safety by Design
Inherently safe fusion processes with no risk of meltdown, no weapons-grade materials, and minimal waste — designed for regulatory confidence.
Our People
Led by Deep Expertise
Our team brings together nuclear physics, engineering, and enterprise leadership.
Leadership
Prof. Prabhat Ranjan
Founder
Abhay K. Jha
Co-founder
Abhinav Jha
Operations Director
Advisors
Prof. Y. C. Saxena
Advisor
Prof. Srinivasan Ganesan
Advisor
Research & Engineering
Nilormi Das
Research Scientist
Dr. Varun Vijay Savadi
Senior Research Scientist
Chandresh Shah
R&D Engineer
Get in Touch
Let's Build the Future Together
We welcome conversations with researchers, clinicians, investors, and anyone passionate about fusion's potential for humanity.
Reach Us
Whether you're exploring collaboration, investment, or simply curious about our work — we'd love to hear from you.